28 results
8-K
VIR
Vir Biotechnology Inc
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
training in internal medicine and pulmonary medicine at the University of California, San Francisco (“UCSF”). He received his research training
DRS/A
EX-10.27
VIR
Vir Biotechnology Inc
7 Aug 19
Draft registration statement (amended)
12:00am
or the Project, including by assisting any party to secure an improper advantage. Training and information on compliance with these requirements are available
S-1
EX-10.27
VIR
Vir Biotechnology Inc
3 Sep 19
IPO registration
4:40pm
or the Project, including by assisting any party to secure an improper advantage. Training and information on compliance with these requirements are available
S-1
EX-10.26
d705npy87owacr1
3 Sep 19
IPO registration
4:40pm
DRS/A
EX-10.26
70fd 9wtsmoees9h
7 Aug 19
Draft registration statement (amended)
12:00am
S-1
EX-10.25
jia4dyloi6446
3 Sep 19
IPO registration
4:40pm
DRS/A
EX-10.25
mdepds2klc6itr
7 Aug 19
Draft registration statement (amended)
12:00am
DEF 14A
v5rb8k2hm8 wdvbqb54y
6 Apr 20
Definitive proxy
4:52pm
DRS
EX-10.54
z7u6wuphy4a0vr8
23 Jun 20
Draft registration statement
12:00am